Back to User profile » Dr Betul Gok Yavuz
Paper published by Dr Betul Gok Yavuz:
Original Research
Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma
Kaseb AO, Guan Y, Gok Yavuz B, Abbas AR, Lu S, Hasanov E, Toh HC, Verret W, Wang Y
Journal of Hepatocellular Carcinoma 2022, 9:1065-1079
Published Date: 11 October 2022